Stay updated on Response to Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Response to Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Response to Immunotherapy in Lung Cancer Clinical Trial page
- ChecktodayChange DetectedDifference2%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference3%
- Check15 days agoChange DetectedDifference2%
- Check22 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of the iCaRe2 cancer research resource and its collaborative model, while adding a list of various cancer types and a new biospecimen description.SummaryDifference31%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 20, 2024.SummaryDifference2%
- Check37 days agoChange DetectedThe page has been updated to include new cancer types such as Pancreatic, Esophageal, and Vaginal Cancer, while removing Stomach, Laryngeal, and Gallbladder Cancer. Additionally, the last update date has changed to March 25, 2025.SummaryDifference3%
Stay in the know with updates to Response to Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Response to Immunotherapy in Lung Cancer Clinical Trial page.